Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.50 |
| ▸ | AKT2 | P31751 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 8/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 8/20 | 0.48 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22615061 | 0.84 | SLC2A3 (0.46) | AKT1AKT2CYP11B1CYP11B2SLC2A1 | |
| SCHEMBL15730473 | 0.81 | AKT1 (0.56) | AKT1AKT2CYP11B1CYP11B2SLC2A1 | |
| SCHEMBL2906472 | 0.81 | GABRA1 (0.42) | AKT1AKT2CYP11B1CYP11B2SLC2A1 | |
| Hydrochloric Acid SCHEMBL18128834 | 0.79 | AKT1 (0.55) | AKT1AKT2CYP11B1CYP11B2SLC2A1 | |
| SCHEMBL22615058 | 0.77 | ALDH1A1 (0.62) | NPC1RAB9AALDH1A1MAPK14 | |
| SCHEMBL4833235 | 0.76 | NPC1 (0.64) | AKT1AKT2SLC2A1NPC1RAB9A | |
| SCHEMBL14810130 | 0.73 | CYP11B2 (0.38) | CYP11B1CYP11B2GABRA1GABRB2CYP19A1 | |
| SCHEMBL16540967 | 0.73 | CYP11B1 (0.43) | CYP11B1CYP11B2GABRA1GABRB2ALDH1A1 | |
| SCHEMBL1318629 | 0.71 | AKT1 (0.53) | AKT1AKT2CYP11B1CYP11B2ALDH1A3 | |
| SCHEMBL15824701 | 0.70 | SLC2A1 (0.54) | SLC2A1NPC1RAB9AMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027124-A1 | SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND PREVENTION OF FIBROSIS | MOEXA PHARMACEUTICALS LTD (CN) | 2026-01-29 | — | — | US | disclosed |
| EP-4558503-A1 | SUBSTITUTED IMIDAZO [1, 2-A] PYRIDINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND PREVENTION OF FIBROSIS | Moexa Pharmaceuticals Limited (HK) | 2025-05-28 | — | — | EP | disclosed |
| WO-2024017144-A1 | SUBSTITUTED IMIDAZO [1, 2-A] PYRIDINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND PREVENTION OF FIBROSIS | MOEXA PHARMACEUTICALS LIMITED (CN) | 2024-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027124-A1 | SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND PREVENTION OF FIBROSIS | NOX4, NOX1, CBR1 | AKT1 2208/4885AKT2 1993/4885CYP11B1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.